AMRI to Present at 27th Annual J.P. Morgan Healthcare Conference.

ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today that it will present and provide an audio webcast of its corporate presentation at the 27th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2009.

AMRI Chief Financial Officer Mark T. Frost will present in a session scheduled for 8 a.m. PST. Interested parties may access the presentation and live audio web cast by visiting the company's website at www.amriglobal.com. In addition, a replay of the webcast will be available for approximately fourteen days in the investor relations area of the company's website at www.amriglobal.com/investor_relations.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.